David Platt - Dec 31, 2022 Form 5 Insider Report for BIOXYTRAN, INC (BIXT)

Role
CEO, Director, 10%+ Owner
Signature
David Platt
Stock symbol
BIXT
Transactions as of
Dec 31, 2022
Transactions value $
-$40,119
Form type
5
Date filed
2/8/2023, 01:00 PM
Previous filing
Feb 8, 2023
Next filing
May 10, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIXT common Gift $0 0 0% $0.00* 411K Jan 7, 2020 by spouse
transaction BIXT common Award $0 0 0% $0.00* 43M Sep 21, 2018 Direct
transaction BIXT common Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $3.8K +1.9M +86.47% $0.00* 4.1M Dec 31, 2022 by NDPD Pharma, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIXT warrant Gift -$43.9K -122K -100% $0.36 0 May 13, 2022 common 122K $2.00 by NDPD Pharma, Inc.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Management ownership in BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership within Davis Platt's filing